Omics Labs

Omics is a biotechnology company focused on leveraging multi-omics data to transform drug discovery and development. Founded by Mostafa Ronaghi, the former CTO of Illumina, the company aims to integrate genomics, proteomics, and other omics layers to provide a comprehensive understanding of human biology. By utilizing advanced computational tools and high-throughput biological assays, Omics seeks to identify novel therapeutic targets and biomarkers for complex diseases. The company's platform is designed to accelerate the transition from data to actionable clinical insights. With significant backing from leading venture capital firms, Omics is positioned at the intersection of high-throughput biology and data science.